Laserfiche WebLink
DocuSign Envelope ID: 06CEAA47-F11 F-421 A-B8CE-390F42C61208 <br /> (c) CorVel's PBM will present a proprietary or state mandated Formulary to Customer. Upon <br /> presentation of identification to a Participating Pharmacy, the Formulary will trigger the <br /> Participating Pharmacy's adjudication system to either: <br /> i. Automatically dispense certain medications, or <br /> Obtain Prior Authorization(PA)approval from claims professional to dispense, <br /> (d) CorVel's PBM will implement a Concurrent Drug Utilization Review("DUR") program <br /> on behalf of Customer,. Concurrent DUR includes a review of the drug history at the time <br /> the prescription is presented. Absent Customer's directions, DUR shall be performed in <br /> accordance with CorVel's PBM's standard service model. <br /> IV. BILLING AND PAYMENTS OF PHARMACY PROGRAM. <br /> (i) Financial obligations of parties. <br /> (i) Customer shall be financially responsible for all drug charges incurred by <br /> claimants for dispensed medications processed under CorVel's PBM. CorVel <br /> assumes no liability for drug charges with the exceptions noted below in subsection <br /> (ii) If the CorVel claims professional determines, upon receipt of CorVel's PBM <br /> invoice, that specific formulary and non-formulary drugs should not have been <br /> dispensed, the CorVel claims professional should inform the PBM as soon as <br /> possible. <br /> 1. The PBM will request a reversal from the Participating Pharmacy. If <br /> granted, CorVel will reverse the drug charges, however, if the Pharmacy <br /> does not grant the PBM's request,Customer is responsible for payment of <br /> the drug charges; CorVel assumes no liability for drug charges with the <br /> exceptions noted below in subsection iii. <br /> (iii)Upon receipt of an invoice,CorVel claims professional may timely dispute charges <br /> for drugs that were dispensed in error,triggering CorVel's PBM to reverse the drug <br /> charges,by notifying CorVel for any of the following reasons: <br /> 1. CorVel's PBM and/or the Participating Pharmacy's violation of <br /> Formulary or Utilization Review Parameters set forth in Customer's DUR <br /> program,or in the Claimant Level Formulary; or <br /> 2. Duplicate or inadvertent entries or other clerical mistakes on a PBM <br /> invoice. <br /> (ii) Invoicing and Payment. <br /> On a per Covered Drug basis CorVel will apply daily for all drug charges and fees <br /> related to the PBM directly to the claim file. <br /> CorVel shall invoice and bill directly all prescription fees to the specific claims file. <br /> CorVel uses Medi-Span as our AWP data source. CorVel's Medi-Span database is <br /> updated daily and AWP values are applied on the date of dispense. <br /> In all states with the exception of California, Customer will be billed the lessor of the <br /> state fee schedule AWP or the CorVel's negotiated rate. <br /> City of Everett,WA—CorVel EC Amendment 3 7-25-2022 <br />